LNA Santé SA (LON: 0OR2)
London
· Delayed Price · Currency is GBP · Price in EUR
22.10
-0.60 (-2.63%)
Jan 20, 2025, 3:55 PM BST
LNA Santé Revenue
LNA Santé had revenue of 389.62M EUR in the half year ending June 30, 2024, with 8.26% growth. This brings the company's revenue in the last twelve months to 762.03M, up 4.10% year-over-year. In the year 2023, LNA Santé had annual revenue of 736.09M with 1.08% growth.
Revenue (ttm)
762.03M EUR
Revenue Growth
+4.10%
P/S Ratio
n/a
Revenue / Employee
97.26K EUR
Employees
7,835
Market Cap
188.51M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 736.09M | 7.86M | 1.08% |
Dec 31, 2022 | 728.22M | 38.73M | 5.62% |
Dec 31, 2021 | 689.49M | 115.60M | 20.14% |
Dec 31, 2020 | 573.89M | 46.03M | 8.72% |
Dec 31, 2019 | 527.86M | -10.90M | -2.02% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |